Email from Dave reiterates what you say. Kim's job done with attaining interim analysis. Only other involvement in the trial was the CEC (clinical events committee) and DSMBs (Data safety monitoring boards) passed on to an experienced person.
Most interesting thing is Dave sent the Email from Europe? Not there on holiday I think.
kim olesson leaves position head of clinical affairs, page-4
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)